PSTV

Conviction 31HealthcareScan · Tue, Sep 8, 2026

Bullish engulfing

PSTV$3.87+6.03%

ResistanceSupportVol 14

Vol MA14 107.38K

May 1May 19Jun 8Jun 25Jul 15Jul 31

Plus Therapeutics IncBiotechnologywww.plustherapeutics.com ↗

Price3.87

Change+6.03%

Gap+0.00%

Rel volume0.79×

Avg volume116.5K

Avg $ vol463.84K

SMA 203.89

SMA 504.66

SMA 2002.35

Price vs 50-16.95%

Price vs 200+64.44%

MA stackmixed

50/200 cross—

Supertrenddown · 4.36

RSI (14)44

MACD hist0.03

MACD cross—

Stoch %K / %D37 / 19

ADX (14)19

+DI / −DI22 / 24

RSI divergenceBullish

MACD divergenceBullish

ATR %+7.19%

ADR %6.24%

52w high7.62

52w low0.1558

From 52w high-49.21%

Above 52w low+2383.95%

New 52w highNo

SqueezeOn · 13d

Bollinger width16.87%

%B0.47

Donchian pos36.78%

Donchian high4.42

Donchian low3.55

AVWAP (52w high)5.13

vs AVWAP high-24.56%

AVWAP (52w low)2.48

vs AVWAP low+56.30%

OBV trendUp

Chaikin MF (20)-0.01

Today vs 20d0.79×

Avg vol (14d)107.38K

Avg vol (20d)116.5K

Avg $ vol (20d)463.84K

Market cap34.49M

RS 3m (vs SPY)-40.92%

RS 6m (vs SPY)+1471.31%

RS line new highNo

Trend template5/8

Technical rank70.0

1 week+1.04%

1 month-6.97%

3 months-36.97%

6 months+1478.95%

1 year+746.27%

YTD+597.30%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value—

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeXNAS

Shares out6.88M

Employees28

ListedThu, Nov 16, 2000

Free float167.16M

Float %97.4%

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction31 / 100

Pattern quality—

Tech rank70.0 / 100

Group rank96 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish engulfing

News sentiment—

Congress activity

Disclosed STOCK Act trades in PSTV

All disclosures →

No recent disclosed trades by Congress in PSTV. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PSTV · 10 buys

Insider	Side	Shares	Value	Traded	Filed
ANDREWS RONALD ASBURY Director · Restricted Stock Units · 2026-05-14	Grant	3.69K	$0	2026-05-14	2026-05-18
Hawkins Richard J Director · Stock Option (Right to Buy) · 2026-05-14	Grant	3.69K	$0	2026-05-14	2026-05-18
Sims Andrew John Hugh MacIntyre Chief Financial Officer · Restricted Stock Units · 2026-05-14	Grant	3.44K	$0	2026-05-14	2026-05-18
Clowes Howard Director · Restricted Stock Units · 2026-05-14	Grant	3.69K	$0	2026-05-14	2026-05-18
HEDRICK MARC H Chief Executive Officer · Restricted Stock Units · 2026-05-14	Grant	23.83K	$0	2026-05-14	2026-05-18
HEDRICK MARC H Chief Executive Officer · Stock Option (Right to Buy) · 2026-05-14	Grant	23.83K	$0	2026-05-14	2026-05-18
van Es-Johansson An Director · Stock Option (Right to Buy) · 2026-05-14	Grant	3.69K	$0	2026-05-14	2026-05-18
Guse Kyle Director · Stock Option (Right to Buy) · 2026-05-14	Grant	3.69K	$0	2026-05-14	2026-05-18
ANDREWS RONALD ASBURY Director · Stock Option (Right to Buy) · 2026-05-14	Grant	3.69K	$0	2026-05-14	2026-05-18
Sims Andrew John Hugh MacIntyre Chief Financial Officer · Stock Option (Right to Buy) · 2026-05-14	Grant	3.44K	$0	2026-05-14	2026-05-18

SEC filings

EDGAR filings in PSTV · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.